Wall Street Zen Downgrades Definitive Healthcare (NASDAQ:DH) to Hold

Definitive Healthcare (NASDAQ:DH) was downgraded by equities research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.

Several other brokerages have also issued reports on DH. BTIG Research reissued a “neutral” rating on shares of Definitive Healthcare in a report on Friday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $1.00 target price on shares of Definitive Healthcare in a report on Wednesday, August 12th. Robert W. Baird set a $1.10 price target on Definitive Healthcare in a report on Friday, May 8th. Morgan Stanley lowered their price target on Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating for the company in a report on Tuesday, August 11th. Finally, Bank of America reiterated an “underperform” rating and set a $0.70 price objective on shares of Definitive Healthcare in a report on Monday, June 29th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $1.47.

Definitive Healthcare Price Performance

Definitive Healthcare stock opened at $1.05 on Friday. The firm has a market capitalization of $112.09 million, a price-to-earnings ratio of -0.66, a PEG ratio of 12.96 and a beta of 1.40. The company’s 50 day simple moving average is $0.76 and its 200 day simple moving average is $0.93. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.86 and a quick ratio of 1.86. Definitive Healthcare has a fifty-two week low of $0.61 and a fifty-two week high of $4.35.

Definitive Healthcare (NASDAQ:DH) last issued its earnings results on Monday, August 10th. The company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.04 by $0.01. The firm had revenue of $55.20 million during the quarter, compared to the consensus estimate of $55.47 million. Definitive Healthcare had a negative net margin of 72.28% and a positive return on equity of 3.55%. Definitive Healthcare has set its FY 2026 guidance at 0.180-0.200 EPS and its Q3 2026 guidance at 0.040-0.050 EPS. As a group, sell-side analysts anticipate that Definitive Healthcare will post 0.06 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Raymond James Financial Inc. bought a new stake in Definitive Healthcare in the 2nd quarter valued at approximately $32,000. Schonfeld Strategic Advisors LLC bought a new position in shares of Definitive Healthcare during the 4th quarter worth approximately $35,000. Bayesian Capital Management LP acquired a new stake in shares of Definitive Healthcare in the second quarter valued at approximately $55,000. Prelude Capital Management LLC acquired a new stake in shares of Definitive Healthcare in the third quarter valued at approximately $64,000. Finally, ExodusPoint Capital Management LP bought a new stake in shares of Definitive Healthcare in the fourth quarter worth $47,000. 98.67% of the stock is currently owned by institutional investors.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.